Caisse De Depot Et Placement Du Quebec Gilead Sciences, Inc. Transaction History
Caisse De Depot Et Placement Du Quebec
- $47 Billion
- Q4 2024
A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 1,025,786 shares of GILD stock, worth $114 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,025,786
Previous 411,727
149.14%
Holding current value
$114 Million
Previous $34.5 Million
174.56%
% of portfolio
0.2%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,092Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.73 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.46 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...